期刊文献+
共找到17篇文章
< 1 >
每页显示 20 50 100
Outcomes of transconjunctival sutureless 27-gauge vitrectomy for vitreoretinal diseases 被引量:9
1
作者 Jie Li San-Mei Liu +4 位作者 Wen-Tao Dong Fang Li Cai-Hong Zhou Xiao-Dan Xu Jie Zhong 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2018年第3期408-415,共8页
AIM: To evaluate the safety and efficacy profile of 27-gauge(27 G) pars plana vitrectomy(PPV) for the treatment of various vitreoretinal diseases.METHODS: The clinical outcomes of 61 eyes(58 patients) with various vit... AIM: To evaluate the safety and efficacy profile of 27-gauge(27 G) pars plana vitrectomy(PPV) for the treatment of various vitreoretinal diseases.METHODS: The clinical outcomes of 61 eyes(58 patients) with various vitreoretinal diseases following 27 G PPV were retrospectively reviewed. RESULTS: Surgical indications included rhegmatogenous retinal detachment(n=24), full-thickness macular hole(n=12), diabetic retinopathy(n=11), vitreous hemorrhage(n=6), Eales disease(n=4), pathological myopia-related vitreous floater(n=2), and macular epiretinal membrane(n=2). The mean follow-up was 166.4±61.3 d(range 98-339 d). The mean log MAR best-corrected visual acuity(BCVA) improved from 1.7±1.1 [0.02 decimal visual acuity(VA) equivalent] preoperatively to 1.2±1.0(0.06 decimal VA equivalent) at the last postoperative visit(P<0.001). The mean operative time was 49.9 min. With the exception of complicated cataract in one eye, no intraoperative complications were encountered. No case required conversion to conventional 20-, 23-or 25 G instrumentation in all surgical maneuvers except for silicone oil infusion, which required a 25 G oil injection syringe. Postoperative complications included transient ocular hypertension, vitreous hemorrhage, persistent intraocular pressure elevation, subconjunctival oil leakage, and recurrent retinal detachment. No cases of hypotony, endophthalmitis, and sclerotomy-related tears were observed.CONCLUSION: The current results suggest that 27 G PPV system is a safe and effective treatment for various vitreoretinal diseases. When learning to perform 27 G PPV,surgeons may encounter a learning curve and should gradually expand surgical indications from easy to pathologically complicated cases. 展开更多
关键词 27 计量器 同等 plana vitrectomy vitreoretinal 疾病
下载PDF
Outcomes of transconjuctival sutureless 27-gauge vitrectomy for stage 4 retinopathy of prematurity
2
作者 Parag K Shah Vishma Prabhu Venkatapathy Narendran 《World Journal of Clinical Pediatrics》 2018年第1期62-66,共5页
AIM To report our initial experience with lens-sparing vitrectomy for stage 4 retinopathy of prematurity using the 27-gauge(G) system.METHODS This retrospective case series involved nine eyes of five babies with activ... AIM To report our initial experience with lens-sparing vitrectomy for stage 4 retinopathy of prematurity using the 27-gauge(G) system.METHODS This retrospective case series involved nine eyes of five babies with active stage 4 ROP, who underwent 27-G lens-sparing vitrectomy. Surgery was done using 27-G valved cannulas and sclerotomies were made 1.5 mm from the limbus. Bilateral sequential vitrectomy was done in eight eyes. RESULTS At one-year follow-up, anatomical outcome was favourable in all nine(100%) eyes. High-speed cutting and smaller sclerotomies were helpful in reducing the intra and post-operative complications. CONCLUSION27-G vitrectomy is well suited for stage 4 ROP surgeries. 展开更多
关键词 vitrectomy RETINOPATHY of PREMATURITY 27-gauge
下载PDF
A sutureless technique for securing leaking sclerotomies with viscoelastic substances in 23-gauge microincision vitrectomy surgery
3
作者 Meng Li Quan-Yong Yi +4 位作者 Jing-Hai Mao Yan-Hong Liao Yan-Yan Wang Qin-Kang Lu Yan Gong 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2023年第5期730-735,共6页
AIM:To introduce and evaluate the clinical efficacy of a new technique,the use of viscoelastic substances(VS)to close leaking sclerotomy in 23G microincision vitrectomy,and to observe its effect on the visual acuity a... AIM:To introduce and evaluate the clinical efficacy of a new technique,the use of viscoelastic substances(VS)to close leaking sclerotomy in 23G microincision vitrectomy,and to observe its effect on the visual acuity and intraocular pressure(IOP)of patients.METHODS:Patients who underwent 23G vitrectomy in Ningbo Eye Hospital before the use of VS technique(June 2019 to September 2020)and after the use of VS technique(October 2020 to December 2021)were selected as the subjects of this study.The above cases underwent operation by the same surgeon and were retrospectively analyzed.VS technique was used as the alternative to suturing,in which a small amount of VS was injected at the leaking sclerotomy and then gently massaged to confirm leaking sclerotomy closure.RESULTS:A total of 174 eyes were covered in the study,including 84 eyes in the control group(before the use of VS technique)and 90 eyes in the VS technique group.The number of eyes that needed to be sutured decreased considerably from 42.9%in the control group to 3.3%in the VS technique group,and the proportion of subconjunctival hemorrhage at 1-2d after surgery decreased remarkably from 35.7%in the control group to 2.2%in the VS technique group.No substantial differences in the incidence of mean IOP and low IOP were found between 1-2 and 3-20d after surgery in the VS technique group.No major complications associated with VS technique were identified during the study.CONCLUSION:In 23G microincision vitrectomy,VS technique is a safe,simple,and effective method to close leaking sclerotomy. 展开更多
关键词 vitrectomy surgery leaking sclerotomy 23-gauge sutureless technique viscoelastic substances intraocular pressure
下载PDF
Ahmed valve implantation for neovascular glaucoma after 23-gauge vitrectomy in eyes with proliferative diabetic retinopathy 被引量:6
4
作者 Yu Cheng Xiao-Hong Liu +1 位作者 Xi Shen Yi-Sheng Zhong 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2013年第3期316-320,共5页
AIM: To report on the outcome of Ahmed glaucoma valve (AGV) implantation for the management of neovascular glaucoma (NVG) after 23-gauge vitrectomy for proliferative diabetic retinopathy (PDR). ·METHODS: Twelve m... AIM: To report on the outcome of Ahmed glaucoma valve (AGV) implantation for the management of neovascular glaucoma (NVG) after 23-gauge vitrectomy for proliferative diabetic retinopathy (PDR). ·METHODS: Twelve medically uncontrolled NVG with earlier 23 -gauge vitrectomy for PDR underwent AGV implantation. The control of intraocular pressure (IOP), preoperative and postoperative best -corrected visual acuity, the development of intraoperative and postoperative complications were evaluated during the follow-up. ·RESULTS: The mean follow-up was 15.4±4.3 months (9-23 months). Mean preoperative IOP was 49.4±5.1mmHg and mean postoperative IOP at the last visit was 17.5 ± 1.6mmHg. The control of IOP was achieved at the final follow-up visits in all patients, however, 8 of 12 patients still needed anti-glaucoma medication (mean number of medications, 0.8±0.7). The visual acuity improved in nine eyes, and the visual acuity unchanged in three eyes at the final follow -up visits. The complications that occurred were minor hyphema in three eyes, choroid detachment in two eyes, and the minor hyphema and choroid detachments were reabsorbed without any surgical intervention. ·CONCLUSION: AGV implantation is a safe and effective procedure that enables successful IOP control and vision preservation in the NVG patients with the history of earlier 23-gauge vitrectomy for PDR. 展开更多
关键词 AHMED GLAUCOMA VALVE IMPLANTATION neovascular GLAUCOMA proliferative diabetic retinopathy 23-gauge vitrectomy
下载PDF
23-Gauge Pars Plana Vitrectomy Alone by a Bimanual Technique for the Removal of Dense Posteriorly Dislocated Crystalline Lens
5
作者 Bingwen Lu Xingwei Wu Qinghua Qiu 《Open Journal of Ophthalmology》 2016年第4期228-239,共12页
Background: We sought to verify the efficacy and safety of transconjunctival 23-gauge pars plana vitrectomy (PPV) alone by our bimanual technique for the removal of dense posteriorly dislocated crystalline lens. Metho... Background: We sought to verify the efficacy and safety of transconjunctival 23-gauge pars plana vitrectomy (PPV) alone by our bimanual technique for the removal of dense posteriorly dislocated crystalline lens. Methods: A retrospective, noncomparative, interventional study of 31 consecutive cases of patients who underwent 23-gauge PPV alone for the removal of dense posteriorly dislocated crystalline lens following complicated cataract surgeries using our bimanual technique was conducted. The main outcomes measured included best-corrected visual acuity (BCVA), preoperative intraocular pressure (IOP), postoperative IOP and postoperative complications. Results: In all 31 cases included in this study, those dense posteriorly dislocated crystalline lenses were successfully removed. The enrolled patients consisted of 17 males and 14 females with a mean age of (75.84 ± 6.17) years (range 59 - 90). The mean follow-up length was (7.61 ± 1.87) months with a range of 6 months to 1 year. The mean preoperative BCVA was 0.22 ± 0.11 logMAR system, and the postoperative BCVA was 0.33 ± 0.07 logMAR system after 6 months of follow-up. The mean operative time was 46.32 ± 4.80 minutes with a range of 38.00 to 57.00 minutes. All of the conjunctival incisions self-closed within the first week with no wound leakage or hemorrhage. The postoperative complications were relatively rare. Conclusions: The removal of dense posteriorly dislocated crystalline lens might be a challenge for micro-incision vitrectomy. Our bimanual technique was proved to be an effective and safe method for those particular dense lenses using 23-gauge alone. 展开更多
关键词 23-gauge Pars Plana vitrectomy Dense Posteriorly Dislocated Crystalline Lens Bimanual Technique Stop-and-Chop DIVIDE-AND-CONQUER
下载PDF
Primary 23-gauge vitreoretinal surgery for rhegmatogenous retinal detachment 被引量:3
6
作者 Ates Yanyali Gokhan Celik +2 位作者 Alper Dincyildiz Fatih Horozoglu Ahmet F. Nohutcu 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2012年第2期226-230,共5页
AIM: To report the effectiveness and safety of primary 23-Gauge (G) vitreoretinal surgery for rhegmatogenous retinal detachment (RRD). · METHODS: In this retrospective study, 49 eyes of 49 consecutive patients wh... AIM: To report the effectiveness and safety of primary 23-Gauge (G) vitreoretinal surgery for rhegmatogenous retinal detachment (RRD). · METHODS: In this retrospective study, 49 eyes of 49 consecutive patients who underwent primary 23-G transconjunctival sutureless vitrectomy (TSV) for RRD between January 2007 and July 2009 at our institution were evaluated. · RESULTS: Mean follow-up time was 8.9±7.7 months (1-28 months). Retinal reattachment was achieved with a single operation in 47(95.9%) of 49 eyes. In two eyes (4.1%), retinal redetachment due to new breaks was successfully treated with reoperation using the 23-G TSV system. Mean logMAR visual acuity was 2.01±0.47 preoperatively and 1.3±0.5 postoperatively (P <0.001, Paired t -test). Mean preoperative intraocular pressure (IOP) was 14.1±2.8mmHg. Mean postoperative IOP was 12.3±3.6mmHg at 1 day, 13.1±2.1mmHg at 1 week, 14.3±2.2mmHg at 1 month. Iatrogenic peripheral retinal break was observed in 1 eye(2.0%) intraoperatively. No sutures were required to close the scleral or conjunctival openings, and no eyes required convertion of surgery to 20-G vitrectomy. · CONCLUSION: Primary 23-G TSV system was observed to be effective and safe in the treatment of RRD. 展开更多
关键词 PARS plana vitrectomy RETINAL DETACHMENT rhegmatogenous RETINAL DETACHMENT transconjunctival SUTURELESS vitrectomy vitreoretinal surgery 23-gauge vitrectomy
下载PDF
27G+/25G+微创玻璃体切割手术治疗玻璃体视网膜疾病的比较 被引量:3
7
作者 白石 韩道新 《国际眼科杂志》 CAS 北大核心 2023年第5期856-859,共4页
目的:对比分析25G+与27G+微创玻璃体切割手术治疗玻璃体视网膜疾病的疗效及安全性。方法:回顾性分析2019-03/2022-04于我院行玻璃体切割手术的玻璃体视网膜病变患者89例89眼的临床资料,根据手术方式分为A组(45例45眼,行25G+微创玻璃体... 目的:对比分析25G+与27G+微创玻璃体切割手术治疗玻璃体视网膜疾病的疗效及安全性。方法:回顾性分析2019-03/2022-04于我院行玻璃体切割手术的玻璃体视网膜病变患者89例89眼的临床资料,根据手术方式分为A组(45例45眼,行25G+微创玻璃体切割手术)和B组(44例44眼,行27G+微创玻璃体切割手术),分析两组患者术中玻璃体切割时间和手术完成时间、手术前后最佳矫正视力(BCVA)和眼压情况及术后主观舒适度和并发症情况。结果:两组术中玻璃体切割时间无差异(P>0.05),但B组手术完成时间短于A组(35.50±14.27min vs 41.73±14.25min,P=0.042)。两组术后BCVA均优于术前(P<0.05),但两组间无显著差异(P>0.05)。两组术后眼压均低于术前(P<0.05),且术后1、7d A组眼压略低于B组(P<0.05)。术后1d, A组主观舒适度评分高于B组(6.13±1.20分vs 3.45±1.17分,P<0.001);术后7d,两组主观舒适度评分无差异(2.18±1.01分vs 1.93±0.87分,P=0.215)。随访期间,A组发生切口渗漏7眼(16%),其中一过性低眼压6眼(13%),术后出现结膜水肿10眼(22%);B组未见切口渗漏及一过性低眼压,术后1d发生结膜水肿2眼(4%)。结论:25G+与27G+微创玻璃体切割手术均可改善玻璃体视网膜病变患者的视力,稳定眼压,且安全,但27G+微创玻璃体切割手术后切口渗漏发生较少,眼压较稳定,手术时间相对缩短,且结膜水肿发生率更低。 展开更多
关键词 玻璃体视网膜疾病 玻璃体切割手术 25G+ 27G+ 最佳矫正视力 眼压
下载PDF
27G微创玻璃体切除手术的发展及应用 被引量:15
8
作者 李杰 刘三梅 +1 位作者 李芳 钟捷 《国际眼科杂志》 CAS 2016年第8期1483-1486,共4页
自二十世纪初25G、23G无缝线玻璃体切除术的相继推出,已将我们带入玻璃体视网膜手术的微创时代约有10余年历史。与传统20G三通道玻璃体切除术相比,25G、23G无缝线微创玻璃体切除术不仅缩小巩膜切口,而且还大大简化了手术程序,缩短了手... 自二十世纪初25G、23G无缝线玻璃体切除术的相继推出,已将我们带入玻璃体视网膜手术的微创时代约有10余年历史。与传统20G三通道玻璃体切除术相比,25G、23G无缝线微创玻璃体切除术不仅缩小巩膜切口,而且还大大简化了手术程序,缩短了手术时间及降低了手术并发症。因此,在过去十余年时间里,越来越多的医生由传统的20G玻璃体切除术转向25G、23G玻璃体切除术。但随着微创玻璃体切除术的普及,无缝线巩膜切口的相关并发症也随之增多。本着"越小越好"的理念,眼科学者开始研究下一代玻切手术,并且得益于不断更新换代的高速玻切机、高通量的照明光源、更精细的制造技术和清晰广角镜的发展,日本学者Oshima于2010年正式推出了27G玻璃体切除术。27G玻璃体切除术较之前的微创玻璃体切除术切口更小,切割速率更高,带给眼底外科医生全新的体验。目前27G甚至更细的玻璃体切除术尚处在继续革新之中,围绕其优缺点、适应证及未来发展也逐渐成为大家关注讨论的焦点。本文在此结合笔者27G玻璃体切除术经验,对27G微创玻璃体切除术玻璃体切除术进行了一个简要的综述。 展开更多
关键词 玻璃体切割术 微创 27G
下载PDF
双通道27G玻璃体切除术治疗硅油填充眼复发性视网膜脱离(英文) 被引量:8
9
作者 刘三梅 李杰 +7 位作者 董文韬 李芳 周采虹 唐晓兰 赵渝宇 江文婕 徐晓单 钟捷 《国际眼科杂志》 CAS 2017年第9期1620-1624,共5页
目的:研究双通道27G玻璃体切除术在硅油填充状态下治疗复发性视网膜脱离的可行性及优缺点。方法:回顾性研究。7例硅油填充眼在随访时发现下方视网膜浅脱离。在硅油填充状态下行双通道27G玻璃体切除术。术中完成视网膜表面增殖膜剥离、... 目的:研究双通道27G玻璃体切除术在硅油填充状态下治疗复发性视网膜脱离的可行性及优缺点。方法:回顾性研究。7例硅油填充眼在随访时发现下方视网膜浅脱离。在硅油填充状态下行双通道27G玻璃体切除术。术中完成视网膜表面增殖膜剥离、视网膜下液抽吸,并在视网膜复位后行硅油下视网膜激光光凝术,根据患眼病情辅以巩膜外垫压或环扎。结果:术后所有患眼视网膜均成功复位,术中未发生严重并发症。所有患眼术后眼表反应轻且视力迅速恢复至术前水平。1眼在术后20d出现视网膜再脱离,经传统的硅油取出联合视网膜复位术成功复位视网膜。结论:双通道27G玻璃体切除术是一个治疗硅油填充眼早期视网膜再脱离的有效方法,可能具有更高的性价比。 展开更多
关键词 双通道玻璃体切除术 27G 复发性视网膜脱离 硅油
下载PDF
27+G微创玻璃体切除术临床运用初步报道 被引量:6
10
作者 刘三梅 钟捷 +3 位作者 李杰 李芳 邓铂林 周采虹 《西南医科大学学报》 2017年第2期144-149,共6页
目的:观察27+G微创玻璃体切术用于治疗玻璃体视网膜疾病的手术效率、安全性及术后反应等,总结初步临床经验。方法:回顾性分析了我院自2015年6月至2016年3月期间所行的61例27+G微创玻璃体切除术。并将同期127例25+G玻璃体切除术病例作为... 目的:观察27+G微创玻璃体切术用于治疗玻璃体视网膜疾病的手术效率、安全性及术后反应等,总结初步临床经验。方法:回顾性分析了我院自2015年6月至2016年3月期间所行的61例27+G微创玻璃体切除术。并将同期127例25+G玻璃体切除术病例作为对照。所有患者术前均行视力、眼压、三面镜、眼部B超及眼底检查,记录手术时间及术中并发症,术后随访6~40周,观察视力、眼压、眼前节反应及眼底等。结果:27+G组61眼,25+G组127眼。平均手术时间分别为(52.7±4.2)min(27+G组)及(59.3±2.8)min(25+G组),两组无明显差异(P=0.151)。术中27+G组无巩膜切口缝合;术后27+G组37眼(60.7%)患眼最佳矫正视力(BCVA)有所改善,而25+G组88眼(69.2%)BCVA有所改善,两组间无显著差异(P=0.24)。术后随访,27+G组术后眼部刺激症状相对25+G组轻,27+G组无一过性低眼压,一过性高眼压发生率同25+G组相比,无明显差异(P=0.215);两组均未发生感染性眼内炎及增殖性玻璃体视网膜病变等。结论:27+G微创玻璃体切除术术后反应轻,巩膜切口恢复快,未见严重手术相关并发症。27+G微创玻璃体切除术安全、实用。 展开更多
关键词 玻璃体切除术 微创 临床运用 增殖性玻璃体视网膜病变 最佳矫正视力 玻璃体视网膜疾病 平均手术时间 眼部刺激症状
下载PDF
27G与25G微创玻璃体切割术治疗孔源性视网膜脱离的对比分析 被引量:17
11
作者 李杰 刘三梅 +2 位作者 李芳 董文韬 钟捷 《眼科新进展》 CAS 北大核心 2018年第11期1050-1054,共5页
目的对比分析27G与25G微创玻璃体切割术(pars plana vitrectomy,PPV)治疗原发性孔源性视网膜脱离(rhegmatogenous retinal cdetachment,RRD)效果,并探讨27G PPV治疗RRD的安全性及有效性。方法回顾分析2015年5月至2017年6月我院开展的微... 目的对比分析27G与25G微创玻璃体切割术(pars plana vitrectomy,PPV)治疗原发性孔源性视网膜脱离(rhegmatogenous retinal cdetachment,RRD)效果,并探讨27G PPV治疗RRD的安全性及有效性。方法回顾分析2015年5月至2017年6月我院开展的微创PPV治疗RRD患者共92例,其中25G组58例,27G组34例。对比分析两组手术时间、视网膜复位率、视力改善及并发症等。结果25G组手术时间为(56. 7±35. 9) min,27G组为(55.7±36.1)min(F=0.049,P=0.852)。单次手术视网膜复位率,25G组为94.8%,27G为91.2%,差异无统计学意义(P=0.666)。25G组与27G组末次随访最佳矫正视力(best correctecd visual acuity,BCVA)均较术前改善,两组间视力改善率(改善>0.2 LogMAR)差异无统计学意义(χ~2=1. 860,P=0.173)。两组均无严重并发症发生。25G组有2眼(3. 4%)发生医源性视网膜裂孔,27G组有1眼(2.9%)发生医源性视网膜裂孔。术后一周内,高眼压(>25mmHg)(1 kPa=7.5mmHg)发生率25G组为25.9%,27G组为11.8%(χ~2=3. 009,P=0.083)。两组均未观察到感染性眼内炎、脉络膜脱离等严重并发症。结论27G微创PPV在手术时间、视网膜复位率、视力改善及并发症方面与25G微创PPV无显著差异。27G微创PPV是治疗RRD的安全有效的手术方式。 展开更多
关键词 27G 25G 微创玻璃体切割术 原发性孔源性视网膜脱离
下载PDF
27G与25G微创玻璃体切除术术后短期指标对比分析 被引量:4
12
作者 李杰 刘三梅 +2 位作者 李芳 董文韬 钟捷 《国际眼科杂志》 CAS 北大核心 2018年第7期1252-1256,共5页
目的:比较27G与25G微创玻璃体切除术治疗玻璃体视网膜疾病术后短期指标,探讨27G微创玻璃体切除术的可行性、安全性及实用性。方法:回顾性分析2016-04/2017-10在我院行27G与25G微创玻璃体切除术治疗玻璃体视网膜疾病患者217例217眼的临... 目的:比较27G与25G微创玻璃体切除术治疗玻璃体视网膜疾病术后短期指标,探讨27G微创玻璃体切除术的可行性、安全性及实用性。方法:回顾性分析2016-04/2017-10在我院行27G与25G微创玻璃体切除术治疗玻璃体视网膜疾病患者217例217眼的临床资料,其中27G组135例,25G组82例。分析两组患者手术时间、术中并发症、术后眼部炎症反应、最佳矫正视力(BCVA)恢复及眼压波动等情况。结果:两组患者均顺利完成手术,27G组无患者术中需改为25G玻璃体切除术。25G组手术时间平均56.4±38.9min,27G组45.5±26.1min,差异有统计学意义(t=2.422,P=0.016),但两组中相同疾病的患者手术时间分别比较,差异均无统计学意义(P>0.05)。术后1wk内,25G组结膜充血、前房闪辉及房水细胞累积评分平均为2.4±1.4、0.7±1、0.5±1分,均高于27G组的相应指标的平均累积评分2.1±1.6、0.3±0.6、0.2±0.4分,差异具有统计学意义(P=0.038、0.011、0.046)。术后第7d,25G组BCVA(Log MAR)较术前改善-0.4±0.9,27G组BCVA(Log MAR)较术前改善-0.2±0.9,差异无统计学意义(t=-1.636,P=0.103)。术后1wk内,25G组发生一过性低眼压16眼(19.5%),27G组21眼(15.6%),差异无统计学意义(χ2=0.565,P=0.452);去除硅油填充的病例后,25G组眼压波动(3.59±0.69mm Hg)与27G组(3.58±0.47mm Hg)比较,差异无统计学意义(t=0.007,P=0.995)。结论:27G微创玻璃体切除术可用于多种视网膜玻璃体疾病的治疗,具有创伤小、手术反应轻等特点,是治疗玻璃体视网膜疾病的一种安全、实用的手术方式。 展开更多
关键词 27G 25G 微创玻璃体切除术 玻璃体视网膜疾病
下载PDF
27G玻璃体切除原位切膜法治疗晚期增殖性糖尿病视网膜病变 被引量:4
13
作者 苏定旺 岑志敏 刘浇艺 《国际眼科杂志》 CAS 北大核心 2018年第7期1310-1312,共3页
目的:探讨27G玻璃体切除原位切膜法治疗晚期增殖性糖尿病视网膜病变(PDR)的临床疗效。方法:收集2017-01/08晚期PDR 10例15眼临床病例,行27G微创玻璃体切除术,采用切割头原位切膜法切除增殖膜,观察术中医源性视网膜裂孔发生率、硅油填充... 目的:探讨27G玻璃体切除原位切膜法治疗晚期增殖性糖尿病视网膜病变(PDR)的临床疗效。方法:收集2017-01/08晚期PDR 10例15眼临床病例,行27G微创玻璃体切除术,采用切割头原位切膜法切除增殖膜,观察术中医源性视网膜裂孔发生率、硅油填充率、术前术后最佳矫正视力、眼压等指标。结果:患者4眼(27%,4/15)术中发生医源性视网膜裂孔;6眼(40%,6/15)硅油填充;术后3mo时仅2眼视力不提高,13眼术后视力提高,最好视力0.6,术前最佳矫正视力分别与术后7d,1、3mo最佳矫正视力比较,差异均有统计学意义(P<0.05);术前平均眼压16.95±6.87mm Hg,术后3mo平均眼压15.27±4.57mm Hg,两者比较差异无统计学意义(P>0.05)。结论:27G玻璃体切除原位切膜法在晚期PDR术中处理视网膜前增殖膜时优势明显,疗效确切,可为晚期复杂PDR的优选术式。 展开更多
关键词 27G玻璃体切除术 硅油填充 糖尿病性视网膜病变 玻璃体出血
下载PDF
International multi-center study of iatrogenic retinal tears in pars plana vitrectomy
14
作者 Omar A.Saleh Rami A.Al-Dwairi +5 位作者 Hasan Mohidat Denis Jusufbegovic Brooke Nesmith Yoreh Barak Michael Mimouni Shlomit Schaal 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2019年第6期996-1000,共5页
AIM: To study and compare the effect of different surgical settings on the development of iatrogenic retinal tears(IRT) in conventional(20-gauge) and microincisional vitrectomy.METHODS: An international retrospective ... AIM: To study and compare the effect of different surgical settings on the development of iatrogenic retinal tears(IRT) in conventional(20-gauge) and microincisional vitrectomy.METHODS: An international retrospective comparative study of 394 patients who had simple vitrectomy at three tertiary centers. Surgeries were performed by four retina surgeons using different viewing systems. Two groups of eyes were compared: microincisional vitrectomy(327 eyes) and conventional(67 eyes) vitrectomy. An iatrogenic tear was defined as the occurrence of one or more peripheral retinal tears during surgery or at any visit in the first 6 wk postoperatively.RESULTS: Mean age was 67±12 y and 55% were female. Iatrogenic tears occurred in 11/394(2.8%) of eyes. The rate of tears was similar among different surgeons and viewing systems(P=0.93 and P=0.76, respectively). Surgical indication, preexisting pseudophakia/aphakia, induction of posterior vitreous detachment(PVD) during surgery, and the use triamcinolone acetonide didn’t significantly affect the rate of tears(P>0.1 for all factors). A higher rate of tears was found in the conventional group compared to the microincisional group(respectively, 7.5%, 1.8%, P=0.02).CONCLUSION: The rate of IRT in vitrectomy is not significantly affected by surgical indication, preexisting PVD or pseudophakia, or use of triamcinolone or different viewing systems but is significantly higher in conventional vitrectomy. Microincisional platforms improve the safety of vitrectomy regardless of the viewing system used. 展开更多
关键词 microincisional vitrectomy IATROGENIC RETINAL TEAR 20-gauge
下载PDF
微创玻璃体切除术后早期高眼压发生的相关因素分析 被引量:7
15
作者 李杰 刘三梅 +2 位作者 李芳 董文韬 钟捷 《实用医院临床杂志》 2018年第5期13-17,共5页
目的探讨微创玻璃体切除术后引起早期高眼压的相关因素。方法 2016年4月至2017年10月我院开展的微创玻璃体切除术治疗玻璃体视网膜疾病的患者217例。观察术后高眼压发生率,并对影响眼压高低的相关因素进行分析。结果微创玻璃体切除术后2... 目的探讨微创玻璃体切除术后引起早期高眼压的相关因素。方法 2016年4月至2017年10月我院开展的微创玻璃体切除术治疗玻璃体视网膜疾病的患者217例。观察术后高眼压发生率,并对影响眼压高低的相关因素进行分析。结果微创玻璃体切除术后26眼(11.98%)发生高眼压。高眼压组术前最佳矫正视力(Log MAR)、手术时间、术后眼压高于无高眼压组;两组间前房闪辉及房水细胞分级差异有统计学意义(P<0.05)。有晶体眼、人工晶体眼及无晶体眼术后高眼压发生率比较,差异无统计学意义(P=0.065)。25 g玻切术组高眼压发生率高于27 g玻切术组(P=0.026)。硅油组高眼压发生率为22.3%,灌注液组为4.7%,空气组无高眼压发生,三组间差异有统计学意义(P<0.001)。糖尿病视网膜病变、眼内填充物(硅油)、术后前房闪辉及术后眼压波动是引起微创玻璃体切除术后早期高眼压的独立危险因素。结论微创玻璃体切除术后早期高眼压的发生受多种因素影响,对于手术时间长、糖尿病视网膜病变患者、眼内填充物为硅油及术后前房炎症反应重的患者尤其要重视术后早期高眼的防治。 展开更多
关键词 微创玻璃体切割术 25g 27g 高眼压 危险因素
下载PDF
微创玻璃体切除术后早期大幅眼压波动的影响因素分析 被引量:3
16
作者 李杰 刘三梅 +3 位作者 李芳 董文韬 于睿超 钟捷 《西南医科大学学报》 2018年第4期339-344,共6页
目的:探讨微创玻璃体切除术后早期大幅眼压波动的相关因素。方法:采用病例对照的研究方式,回顾性分析2016年4月至2017年10月微创玻璃体切除术(简称:玻切术)治疗玻璃体视网膜疾病共217例。术后眼压波动≥8 mmHg定义为大幅眼压波动,<8 ... 目的:探讨微创玻璃体切除术后早期大幅眼压波动的相关因素。方法:采用病例对照的研究方式,回顾性分析2016年4月至2017年10月微创玻璃体切除术(简称:玻切术)治疗玻璃体视网膜疾病共217例。术后眼压波动≥8 mmHg定义为大幅眼压波动,<8 mmHg为小幅眼压波动,观察分析术后大幅眼压波动相关因素。结果:术后1周大幅眼压波动组共45人(20.7%),小幅眼压波动组172人。大幅眼压波动组平均手术时间为(68.5±44.5)min,小幅眼压波动组平均手术时间为(44.9±26.0)min,差异具有统计学意义(P<0.001)。联合白内障超声乳化术与单纯玻切术相比,大幅眼压波动发生率分别为8.51%及24.12%,两组差异具有统计学意义(P=0.019)。术后房水细胞分级为0至4级时,大幅眼压波动发生率分别为19.08%、20.00%、66.67%、25.00%及0%,差异具有统计学意义(P=0.044)。回归分析发现手术时间、房水细胞是术后早期大幅眼压波动的危险因素。结论:玻切术后大幅眼压波动与多种围手术期因素有关,其中手术时间、前房炎症反应是引起术后早期大幅眼压波动的危险因素。 展开更多
关键词 微创玻璃体切割术 25G 27G 眼压波动 危险因素
下载PDF
25 G与27 G玻璃体切割手术治疗孔源性视网膜脱离的meta分析
17
作者 向小红 徐琴 吕红彬 《重庆医学》 CAS 2023年第22期3470-3474,共5页
目的比较25 G与27 G玻璃体切割手术治疗孔源性视网膜脱离的有效性及安全性。方法检索英文数据库PubMed、Web of Science、The Cochrane Library和中文数据库万方、中国知网及维普,查找关于25 G与27 G玻璃体切割手术治疗孔源性视网膜脱... 目的比较25 G与27 G玻璃体切割手术治疗孔源性视网膜脱离的有效性及安全性。方法检索英文数据库PubMed、Web of Science、The Cochrane Library和中文数据库万方、中国知网及维普,查找关于25 G与27 G玻璃体切割手术治疗孔源性视网膜脱离的临床研究,包括随机或非随机对照病例研究、回顾性病例对照研究。检索时限均为从建库到2021年8月。由两位研究者根据纳入与排除标准独立筛选文献、提取资料并评价质量后,使用RevMan5.4软件进行meta分析,用Cochrane协作工具评估每项研究中的偏倚风险。结果共纳入10项研究,共计715只眼,其中25 G有396只眼,27 G有319只眼。meta分析结果显示,25 G与27 G手术时间、视网膜复位率、末次随访BCVA、术后并发症发生率比较,差异无统计学意义(P>0.05)。与25 G比较,27 G术中并发症发生率(RR=2.31,95%CI:1.03~5.17,P=0.04)更高,术后低眼压发生率(RR=0.25,95%CI:0.10~0.63,P<0.01)和高眼压发生率(RR=0.54,95%CI:0.33~0.91,P=0.02)更低,差异有统计学意义(P<0.05)。结论25 G玻璃体切割手术术中并发症少,27 G术后眼压更稳定。 展开更多
关键词 25 G玻璃体切割手术 27 G玻璃体切割手术 孔源性视网膜脱离 有效性 安全性 META分析
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部